Ryuhei Okada

Also affiliated with Tokyo Institute of Psychiatry, Institute of Science Tokyo, The University of Tokyo

MedicineEngineeringImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response”.

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response

OncoImmunology(2022)10.1080/2162402x.2022.2152248

N/A

0.927DataRank · unranked

24 citations

Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model

Cancer Science(2021)10.1111/cas.15013

N/A

0.821DataRank · unranked

25 citations

Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama +5 more

Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0517

N/A

0.661DataRank · unranked

81 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Daiki Fujimura, Hiroaki Wakiyama +5 more

Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green

Molecular Pharmaceutics(2021)10.1021/acs.molpharmaceut.0c01107

N/A

0.483DataRank · unranked

24 citations

Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato +3 more

Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green

Cancer Science(2021)10.1111/cas.14809

N/A

0.464DataRank · unranked

21 citations

Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato +3 more

Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03216-2

N/A

0.442DataRank · unranked

18 citations

Mayuko Hashimoto, Hina Matsushita, Shion Masuyama, Rina Yoshida, Ryuhei Okada +10 more

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

Pharmaceutics(2022)10.3390/pharmaceutics14102037

N/A

0.373DataRank · unranked

11 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +4 more

Comparison of the Effectiveness of IgG Antibody versus F(ab′)2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy

Molecular Pharmaceutics(2022)10.1021/acs.molpharmaceut.2c00242

N/A

0.330DataRank · unranked

8 citations

Ryuhei Okada, Aki Furusawa, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima +4 more

Wound healing after excision of subcutaneous tumors treated with near‐infrared photoimmunotherapy

Cancer Medicine(2020)10.1002/cam4.3247

N/A

0.269DataRank · unranked

5 citations

Fuyuki Inagaki, Takuya Kato, Ryuhei Okada, Hiroaki Wakiyama, Aki Furusawa +3 more

Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.1c00184

N/A

0DataRank · unranked

31 citations

Ryuhei Okada, Yuto Goto, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama +9 more

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0041

N/A

0DataRank · unranked

53 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0313

N/A

0DataRank · unranked

31 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model

OncoImmunology(2022)10.1080/2162402x.2021.2019922

N/A

0DataRank · unranked

30 citations

Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto +5 more

Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer

Cancer Science(2022)10.1111/cas.15466

N/A

0DataRank · unranked

24 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy

Cancer Immunology Immunotherapy(2022)10.1007/s00262-021-03124-x

N/A

0DataRank · unranked

22 citations

Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Daiki Fujimura +6 more

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03205-5

N/A

0DataRank · unranked

14 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Hideyuki Furumoto +5 more

Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114390

N/A

0DataRank · unranked

14 citations

Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Takuya Kato, Daiki Fujimura +6 more

Data from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

(2023)10.1158/2326-6066.c.6551037

N/A

0DataRank · unranked

0 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Antitumor host immunity enhanced by near‐infrared photoimmunotherapy

Cancer Science(2024)10.1111/cas.16427

N/A

0DataRank · unranked

9 citations

Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L. Choyke, Hisataka Kobayashi +1 more

Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment

Cancer Science(2024)10.1111/cas.16195

N/A

0DataRank · unranked

12 citations

Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima +5 more

Urinary IR700 Ligand as an Early Biomarker of Therapeutic Efficacy of Near-Infrared Photoimmunotherapy

ACS Omega(2025)10.1021/acsomega.4c09850

N/A

0DataRank · unranked

1 citations

Daiki Fujimura, Aki Furusawa, Hiroshi Fukushima, Ryuhei Okada, Tairo Ogura +4 more

Uncovering cell cycle-dependent effects on cell survival in near-infrared photoimmunotherapy

Experimental Cell Research(2025)10.1016/j.yexcr.2025.114570

N/A

0DataRank · unranked

1 citations

Yuriko Igarashi, Hitomi Nojima, Mio Nakayama, Ryuhei Okada, Ryosuke Takahashi +3 more

Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab–IR700 for Near-Infrared Photoimmunotherapy

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00262

N/A

0DataRank · unranked

20 citations

Fuyuki Inagaki, Ryuhei Okada, Adrian Rosenberg, Aki Furusawa, Peter L. Choyke +2 more

Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy

Cancers(2020)10.3390/cancers12123747

N/A

0DataRank · unranked

39 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Yasuhiro Maruoka +3 more

Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors

Cancers(2020)10.3390/cancers12092575

N/A

0DataRank · unranked

36 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato +4 more

Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice

Molecular Imaging(2020)10.1177/1536012120934965

N/A

0DataRank · unranked

6 citations

Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama +4 more

Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity

Advanced Therapeutics(2021)10.1002/adtp.202000269

N/A

0DataRank · unranked

46 citations

Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Peter L. Choyke +2 more

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

EBioMedicine(2021)10.1016/j.ebiom.2021.103345

N/A

0DataRank · unranked

45 citations

Aki Furusawa, Daniel W. Vermeer, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato +6 more

Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression

Cancer Research(2021)10.1158/0008-5472.can-20-2673

N/A

0DataRank · unranked

37 citations

Colleen P. Olkowski, Kelly Lane, Olga Vasalatiy, Biying Xu, Ryuhei Okada +5 more

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0470

N/A

0DataRank · unranked

34 citations

Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more